Latest placebo Stories
Both doses of investigational drug sarilumab met all three co-primary endpoints PARIS and TARRYTOWN, N.Y., June 12, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY)
Phase 3 Program Underway to Further Assess Brodalumab as Potential Treatment for People Living With Psoriatic Arthritis THOUSAND OAKS, Calif.
Data Presented from Company's Pain, Cancer Immunotherapy, and Inappetence Programs KANSAS CITY, Kan., June 9, 2014 /PRNewswire/ --
Pain medicines often lead to constipation for patients seeking long-term pain relief, but an investigational once-daily drug may help.
-Study appears in June 1 online edition- NORTHBROOK, Ill. and SAN FRANCISCO, JUNE 1, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S.
Women treated with Tefina(TM) 0.6 mg reported a statistically significant increase in orgasms versus placebo TORONTO, May 28, 2014 /CNW/ -
A new research study from Brigham and Women's Hospital (BWH) that compares low-dose oral estrogen and low-dose non-hormonal venlafaxine hydrochloride extended release (XR) to placebo were both found effective in reducing the number of hot flashes and night sweats reported by menopausal women.
New York Times Best Seller 'You Are the Placebo' is an insightful book that shows how much power our mind has, and how meditation can help us to overcome various difficulties in life.
LONDON, May 19, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE: GSK) today presented data at the American Thoracic Society (ATS) from a late-stage clinical study.
- Investor Conference Call and Webcast Today at 8 p.m. EDT (5 p.m. PDT) - BRISBANE, Calif., May 18, 2014 /PRNewswire/ -- InterMune, Inc.
- An armed gangster.